In late July, The Motley Fool started our "11 O'Clock Stock" series, which challenged our analysts to pick 50 stocks over 50 weekdays. While we're only a short way into watching this group of stocks that we think will be long-term winners, many have already seen impressive gains while others have seen set-backs.
In this column, we're going to take a close look at three stocks that have taken off and three that are lagging behind.
Three stocks soaring
One of the better-performing sectors in the portfolio has been the semiconductor industry. Checking in with the "11 O'Clock Stock" CAPS page, Texas Instruments
Of particular note was Qualcomm's outstanding quarter. The rise of Google's Android operating system has been a boon to the company; not only does it create more demand for smartphones that sell for higher prices and thus give Qualcomm more licensing revenue, but Qualcomm has also become a popular chip supplier for Android phones. Estimates from consulting firm PRTM say Qualcomm chips can be found in 77% of current Android phones.
However, another catalyst might be right around the corner. Rising inventories during the quarter hinted that Qualcomm could be building out supplies for a Verizon iPhone in early 2011. Even more enticing is the possibility of Apple
- Click here to see Qualcomm's buy recommendation
- Click here to see Texas Instrument's buy recommendation
- Click here to see Marvell's buy recommendation
Three stocks sagging
One of the portfolio laggards facing the most pressure recently has been National Bank of Greece
Two other portfolio laggards are generic drug maker Teva Pharmaceutical
While the rationale for EnerNOC's sell-off is fairly obvious, there's little in the way of news to explain Teva's underperformance since its recommendation two months ago. If you were intrigued by the original write-up on the company, but were waiting on a better value from the company, now might be a good time to take another look or add the company to your watchlist.
- Click here to see National Bank of Greece's buy recommendation
- Click here to see EnerNOC's buy recommendation
- Click here to see Teva's buy recommendation
If you're interested in seeing more selections from our "11 O'Clock Stock" series, we've put together a special report highlighting five of our top ideas -- with two extra bonus picks for free. You can get access to the report by clicking here now.